查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375902

冠状动脉支架市场规模、份额、趋势分析报告：2023-2030 年按产品、地区和细分市场分類的趋势

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

冠状动脉支架市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球冠状动脉支架市场规模预计将达到 121 亿美元。

预计2023年至2030年该市场将以3.1%的年复合成长率扩张。微创手术和经皮冠状动脉介入治疗（PCI）手术的日益普及预计将在未来年度推动市场发展。例如，根据《韩国胸腔心血管外科杂誌》报道，2016年冠状动脉疾病（CAD）的PCI比例78%，全国PCI比例96%，显着高于世界平均。因此，随着 CAD罹患率空前增加，这些 CAD 患者接受 PCI 的比例预计会增加，增加对有效冠状动脉支架置放技术的需求。

技术进步和第二代药物释放型支架的推出进一步推动了成长。例如，雅培实验室的 XIENCE Sierra 于 2018 年 5 月成为美国首个核准用于 CTO 的 DES。美敦力 (Medtronic) 于 2019 年初效仿，获得 FDA核准在 CTO 适应症中使用其 Resolute 系列 DES。此外，多家公司最近在美国推出了新版本的冠状动脉支架系统，其中最着名的是波士顿科学公司于 2021 年 1 月推出的 Synergy Megatron 以及雅培实验室于 2021 年 6 月推出的 XIENCE Skypoint。

COVID-19大流行对冠状动脉支架市场产生了负面影响。根据世界各地医学协会的指导方针，手术推迟主要影响合格的患者的非紧急和选择性手术。例如，ACC（美国心臟病学会）2020 年指南建议在 COVID-19 爆发高峰期间推迟 CTO 干预和监测血管造影术等非紧急手术。这些指南影响着世界各地医生的治疗决策。此外，根据欧洲心臟学会的建议，所有紧急和紧急PCI手术（STEMI、高或中危NSTEMI、心源性休克、不稳定心绞痛的治疗）应在疫情高峰期及之后进行。在COVID-19 捲土重来期间，应继续进行治疗，而仅应延后选择性PCI 手术（CTO 介入或NYHA II 症状的治疗）。

此外，冠状动脉支架市场从 COVID-19 大流行中復苏预计将得益于紧急 PCI 手术的持续执行和非选择性手术运转率的提高。

冠状动脉支架市场是由一般公共机构医疗保险和医疗补助服务中心 (CMS) 和私人付款人提供的报销保险所推动的。颈动脉置入术的保险范围是基于国家保险范围的确定，其中包括产品和服务提供者。从 2020 年 1 月开始，医疗保险和医疗补助服务中心 (CMS)提案对门诊手术中心 (ASC) 进行的特定血管成形术和支架置入置入术进行报销，预计将在预测期内增加市场收益。

冠状动脉支架市场报告亮点

  • 随着高龄化和合格PCI 条件的患者数量的增加，采用冠状动脉支架装置治疗的 PCI 手术总数将会增加，新技术和治疗严重病变的能力也会增加。
  • 生物可吸收血管支架可以在冠状动脉疾病的治疗中暂时放置在患者的心臟中，三年内降解以方便未来的治疗，并在患者体内完全溶解，由于多种优势，预计将成为增长第二快的领域例如：
  • 成功的临床试验证明 DES 优于标准 BMS。因此，DES 将在 2021 年占据市场主导地位。
  • 北美在冠状动脉支架市场占据主导地位，2022 年收益占有率最大，为 32.6%，预计在可预见的未来将继续保持同样的趋势。
  • 亚太地区的冠状动脉支架市场预计将呈现最快的成长速度。该市场受到其他变数的推动，例如增强的 CAD 筛检、经济成长、法规更新以及澳大利亚和韩国等一些国家的显着优惠报销。

目录

第1章调查方法和范围

第2章执行摘要

第3章冠状动脉支架变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 冠状动脉支架市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章冠状动脉支架：产品估算与趋势分析

  • 冠状动脉支架市场：要点
  • 冠状动脉支架市场：2022 年和 2030 年趋势和市场占有率分析
  • 裸金属支架（BMS）
    • 裸金属支架
  • 药物释放型支架（DES）
    • 药物释放型支架
  • 生物可吸收血管支架
    • 2018年至2030年生物可吸收血管支架市场估计与预测

第5章冠状动脉支架市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的冠状动脉支架市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Terumo Corporation
    • B Braun Melsungen AG
    • Biotronik
    • Stentys SA
    • MicroPort Scientific Corporation
    • CR Bard, Inc.
    • Cook Medical
Product Code: GVR-1-68038-106-1

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 12.10 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 3.1% from 2023 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary stents Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Coronary Stents Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Coronary stents: Product Estimates & Trend Analysis

  • 4.1. Coronary Stents Market: Key Takeaways
  • 4.2. Coronary Stents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bare Metal Stents (BMS)
    • 4.3.1. Bare Metal Stents (BMS) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Drug-Eluting Stents (DES)
    • 4.4.1. Drug-Eluting Stents (DES) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Biodegradable
      • 4.4.1.1.1. Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Non-Biodegradable
      • 4.4.1.2.1. Non-Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Bioresorbable Vascular Scaffold
    • 4.5.1. Bioresorbable vascular scaffold market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Coronary Stents Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Terumo Corporation
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun Melsungen AG
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Biotronik
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Stentys SA
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MicroPort Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. C.R. Bard, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Cook Medical
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 4 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 8 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 18 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 19 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 31 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Coronary stents: Market outlook
  • Fig. 9 Coronary stents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Coronary stents market driver impact
  • Fig. 15 Coronary stents market restraint impact
  • Fig. 16 Coronary stents market strategic initiatives analysis
  • Fig. 17 Coronary stents market: Product movement analysis
  • Fig. 18 Coronary stents market: Product outlook and key takeaways
  • Fig. 19 Bare metal stents (BMS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Drug-eluting stents (DES) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Non-Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Bioresorbable vascular scaffold market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global coronary stents market: Regional movement analysis
  • Fig. 25 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)